Ownership history in PAYDEN & RYGEL · 26 quarters on record
This page tracks every 13F SEC filing in which PAYDEN & RYGEL reported a position in CVS/CAREMARK COM (CVS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 260,200 | -1,300 | -0.5% | 1.43% | $20.6M | $78.71 |
| 2025 Q3 | ADDED | 261,500 | +161,600 | +161.8% | 1.63% | $19.7M | $74.17 |
| 2024 Q3 | REDUCED | 99,900 | -219,100 | -68.7% | 0.48% | $6.3M | $59.15 |
| 2023 Q4 | ADDED | 319,000 | +217,600 | +214.6% | 1.75% | $25.2M | $72.09 |
| 2023 Q2 | ADDED | 101,400 | +97,300 | +2373.2% | 0.50% | $7.0M | $62.07 |
| 2023 Q1 | REDUCED | 4,100 | -432,100 | -99.1% | 0.02% | $305K | $66.17 |
| 2022 Q4 | ADDED | 436,200 | +29,000 | +7.1% | 2.17% | $40.6M | $82.42 |
| 2022 Q3 | ADDED | 407,200 | +8,700 | +2.2% | 2.27% | $38.8M | $83.84 |
| 2022 Q2 | ADDED | 398,500 | +821 | +0.2% | 2.22% | $36.9M | $80.99 |
| 2022 Q1 | REDUCED | 397,679 | -114,700 | -22.4% | 2.03% | $40.2M | $88.00 |
As of 2025 Q4 — sorted by position size